BIOLASE is anticipating first-quarter net revenue to exceed $10.0M, representing relatively flat revenue compared to the year-ago quarter. The Company sees FY23 net revenue to increase at least 25% year over year and expects to achieve positive adjusted EBITDA results for the FY23.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on BIOL:
